Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex

Area of Science:

• Neuroscience
• Pharmacology
• Genomics

Background:

• Statins are known to reduce Alzheimer's disease risk, but the underlying mechanisms are unclear.
• Cholesterol reduction is not the sole factor; pleiotropic effects of statins likely play a role.
• Understanding statin's molecular targets in the brain is crucial for Alzheimer's disease research.

Purpose of the Study:

• To investigate the molecular mechanisms of statins in the brain.
• To identify gene expression patterns affected by different statins (lovastatin, pravastatin, simvastatin).
• To explore potential neuroprotective pathways influenced by statins.

Main Methods:

• DNA microarrays were used to analyze gene expression in mouse cerebral cortex.
• Chronic treatment with three different statins was administered.
• Liquid chromatography/tandem mass spectrometry measured statin levels in the brain.

Main Results:

• Fifteen genes related to cell growth, signaling, and trafficking were consistently altered by all three statins.
• Simvastatin exhibited the most substantial effect, modifying 23 additional genes, including those in apoptotic pathways.
• All tested statins were detected in the cerebral cortex and were rapidly cleared.

Conclusions:

• Statins influence distinct gene expression patterns in the brain, offering potential neuroprotective mechanisms against Alzheimer's disease.
• Simvastatin's impact on apoptotic pathways warrants further investigation.
• These findings provide a foundation for future research into statin efficacy for Alzheimer's disease.